CymitQuimica logo

Ombrabulin

Ref. 3D-GHA81648

50mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

Ombrabulin
Biosynth

    Product Information

    Name:Ombrabulin
    Brand:Biosynth
    Description:Ombrabulin is a potential anticancer agent that inhibits the formation of new blood vessels in solid tumours. It blocks angiogenesis, the process by which new blood vessels are formed from existing ones. Ombrabulin does not affect normal cells and is rapidly cleared from the body with no apparent side effects. Ombrabulin has been shown to be effective against docetaxel-resistant breast cancer in animal models, and it may also be active against other solid tumours such as prostate cancer. Ombrabulin binds to the AT1 receptor and activates a G-protein coupled receptor signaling pathway, resulting in inhibition of angiogenesis.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:402.44 g/mol
    Formula:C21H26N2O6
    Purity:Min. 95%

    Inquiry about discontinued product: Ombrabulin

    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.